Clinical Research Directory
Browse clinical research sites, groups, and studies.
PENTAGON: MS-Related Disability Worsening and Thalamic Volume Loss
Sponsor: Jung Diagnostics GmbH
Summary
PENTAGON is an observational, non-interventional, multicenter, prospective cohort study conducted at approximately 20 neurology centers and affiliated radiology centers across Germany. It investigates whether loss of thalamic volume (TVL) is an independent driver of disability progression in patients with relapsing-remitting multiple sclerosis (MS). The study observes two groups: patients with active MS (receiving or about to receive first- or second-line disease-modifying therapies) and patients with progressive MS. Over a 24-month primary observation period - extendable to 72 months - MS-related disability is measured with the Expanded Disability Status Scale (EDSS), and whole-brain and thalamic volumes are quantified from standardized high-resolution T1-weighted MRI using validated deep-learning methods. The primary objective is to demonstrate that the change in MS-related disability over 24 months is inversely associated with the change in thalamic volume over the same period. No procedures beyond routine clinical care are required.
Official title: An Observational, Non-interventional, Multicenter, Prospective Study to Explore the Association of MS-related Disability Worsening and Loss of Thalamus Volume.
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
OBSERVATIONAL
Enrollment
2400
Start Date
2022-07-01
Completion Date
2033-06-30
Last Updated
2026-08-10
Healthy Volunteers
No
Conditions
Interventions
Disease-Modifying Therapies (DMTs)
Disease-Modifying Therapies (DMTs)
Locations (1)
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
Dresden, Germany